Related Experiment Video
Updated: Aug 19, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Livedo reticularis associated with interferon alpha therapy in two melanoma patients
D P Ruiz-Genao1, M J García-F-Villalta, A Hernández-Núñez
1Department of Dermatology, Hospital Universitario de La Princesa, 28006 Madrid, Spain. diana@aedv.es
Abstract:
We report two patients who developed intense livedo reticularis clearly related to the administration of interferon alpha 2b as an adjuvant therapy for melanoma. Histological studies showed scattered perivascular infiltrates without vasculitis. Laboratory tests excluded any underlying condition. Resolution of the symptoms was observed in both patients when interferon alpha was withdrawn. These cases highlight the occurrence of livedo reticularis as an uncommon side-effect of interferon alpha treatment.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy